Annual Report 2019

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2019 105 The United Laboratories International Holdings Limited Annual Report 2019 16. EARNINGS PER SHARE (Continued) Number of shares 2019 2018 ‘000 ‘000 Weighted average number of ordinary shares for the purpose of basic earnings per share 1,639,725 1,633,778 Effect of dilutive potential ordinary shares: Effect on convertible bonds – 200,570 Weighted average number of ordinary shares for the purpose of diluted earnings per share 1,639,725 1,834,348 The computation of diluted earnings per share for the year ended 31 December 2019 does not assume the conversion of the Company’s outstanding convertible bonds since their exercise would result in an increase in earnings per share.